Pain & Central Nervous System Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain & Central Nervous System Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Pain
Human Chromaffin Cell Grafts May Provide Relief When Opioids Fail
September 9th, 2000
Adrenal medullary allografts may provide relief for patients suffering from chronic, intractable cancer pain when opioids are no longer effective or feasible, researchers writing in Pain report. "A number of pre-clinical studies have demonstrated the value of adrenal medullary allografts in the management of chronic pain," explained Y. Lazorthes and colleagues in France ("Human chromaffin cell graft into the CSF for cancer pain management: A prospective Phase II clinical study," Pain, 2000;87(1):19-32). Lazorthes et al. studied 15 cancer patients suffering from intractable pain for which opioid control - in the form of daily intrathecal...
Source: Pain & Central Nervous System Week (2000-09-09)
|
